Skip to main content
OpenTrials

Clinical trial condition

Endocrine Gland Neoplasms

Explore clinical trials studying Endocrine Gland Neoplasms. Study availability and eligibility vary by location and protocol.

6,073 public trials 1,365 recruiting studies
Refine in advanced search Browse all conditions

Endocrine Gland Neoplasms trial results

Active, Not Recruiting

Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors

NCT01824875

Conditions
Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +23 more
Locations
  • Kaiser Anaheim Medical Center Anaheim, California, United States
  • Kaiser Permanente-Deer Valley Medical Center Antioch, California, United States
  • Kaiser Permanente Medical Group - Baldwin Park Baldwin Park, California, United States
  • Kaiser Foundation Hospital Bellflower, California, United States
View all 323 locations
View Trial Details
Active, Not Recruiting

Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC)

NCT05642962

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +18 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Active, Not Recruiting

ADP-A2M4CD8 Monotherapy and in Combination With Nivolumab in HLA-A2+ Subjects With MAGE-A4 Positive Ovarian Cancer (SURPASS-3)

NCT05601752

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • Honor Health Scottsdale, Arizona, United States
  • City of Hope Duarte, California, United States
  • Augusta University Augusta, Georgia, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
View all 23 locations
View Trial Details
Active, Not Recruiting

Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies

NCT04644068

Conditions
Additional Indications Below for Module 4 and 5, Adnexal Diseases, Biliary Cancer, +66 more
Locations
  • Research Site Boston, Massachusetts, United States
  • Research Site Boston, Massachusetts, United States
  • Research Site New York, United States
  • Research Site Oklahoma City, Oklahoma, United States
View all 68 locations
View Trial Details

Related conditions